NEWS & EVENTS
List
Icon
-
Taiwan FDA granted Market License of Oxaliplatin Injection 5mg/mL "GBC"MORE > -
Zhunan Site Dedicated Oncology(Cytotoxic) Fulvestrant API Plant obtained Taiwan FDA PIC/S GMP Certification.MORE > -
Zhunan Site Dedicated Peptide Synthesis Glucagon API Plant obtained Taiwan FDA PIC/S GMP Certification.MORE > -
Taiwan FDA granted Market License of Acyclovir Lyophilized Inj. 250mg "GBC"MORE > -
Zhunan Site Dedicated Oncology(Cytotoxic) Aseptic Sol. Injectable Vial Commercial Plant obtained TFDA PIC/S GMP Certification.MORE > -
Taiwan FDA granted Market License of Bortezomib for Injection 3.5mg "GBC"MORE >